Updated Monday, 11/30. Five IPOs and two SPACs are scheduled for the week ahead, with a wave of Monday morning launches kicking off the December IPO blitz as expected. Chinese education technology group ...read more
Four IPOs are expected to raise $2 billion before the Fourth of July, led by commercial data analytics provider Dun & Bradstreet (DNB). Dun & Bradstreet (DNB) plans to raise $1.3 billion at a market cap of $8 billion. The...read more
Legend Biotech, a clinical stage CAR-T immuno-oncology biotech being spun out of GenScript, raised $424 million by offering 18.4 million ADSs at $23, above the range of $18 to $20. Legend Biotech plans to list on the Nasdaq under the symbol LEGN. Morgan...read more
IPOs are once again gaining steam and the calendar is flush with deals. With the IPO Index near all-time highs (tracked by NYSE: IPO), there are now eight offerings slated to price, making it...read more
US IPO Week Ahead: A flurry of launches forecasted to kick off December IPO blitz
Updated Monday, 11/30. Five IPOs and two SPACs are scheduled for the week ahead, with a wave of Monday morning launches kicking off the December IPO blitz as expected. Chinese education technology group ...read more
US IPO Week Ahead: Dun & Bradstreet returns to public market in shortened 4 IPO week
Four IPOs are expected to raise $2 billion before the Fourth of July, led by commercial data analytics provider Dun & Bradstreet (DNB). Dun & Bradstreet (DNB) plans to raise $1.3 billion at a market cap of $8 billion. The...read more
Legend Biotech prices IPO above the range at $23
Legend Biotech, a clinical stage CAR-T immuno-oncology biotech being spun out of GenScript, raised $424 million by offering 18.4 million ADSs at $23, above the range of $18 to $20. Legend Biotech plans to list on the Nasdaq under the symbol LEGN. Morgan...read more
This is the IPO market’s busiest week of the year with 8 deals on the calendar
IPOs are once again gaining steam and the calendar is flush with deals. With the IPO Index near all-time highs (tracked by NYSE: IPO), there are now eight offerings slated to price, making it...read more